Submitted by Anonymous (not verified) on 1 September 2023 - 15:40
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 30/03/2023, Revision: 2, Status: Authorised
Source: